Frontlight ResearchEarly access
CompletedNo phase
A Multicenter, Observational, Single Arm Study of the TECNIS Presbyopia-correcting Intraocular Lens
Key facts
- Who runs it
- Johnson & Johnson Surgical Vision, Inc.
- Where
- Australia, Austria, France, Germany, India, Netherlands, South Korea, and Spain20 sites in 8 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 307 people enrolled
- Started
- 10 Apr 2024
- Ended
- 30 Jun 2025
- Type of study
- Observational
- Treatments tested
- Intervention
- Record updated
- 5 June 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patients who are bilaterally implanted with TECNIS PC IOL and are at least 45 days postoperative from their second eye surgery
- Clear intraocular media
- Signed informed consent and data protection documentation
- Availability, willingness, ability, and sufficient cognitive awareness to comply with examination procedures
- Ability to understand, read, and write English or the local language in which the informed consent and questionnaires are provided
Who cannot take part
- Use of systemic or ocular medication that may affect vision
- Concurrent participation in another clinical trial
- Acute or chronic disease or condition, ocular trauma or surgery that may confound results
- Subjects with ongoing adverse events that might impact outcomes during the study
- Patients with amblyopia, strabismus, nystagmus
This trial has no sites in United States.
It has sites in 8 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Ambispective post-market data collection on visual symptoms, patient satisfaction and surgeon experience with the TECNIS PC IOL.
Treatments tested
- Intervention
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 5 June 2026